Author

David A. Katz

ORCID 0000-0002-4400-5669Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

Caleb Schmicker· 1 shared Jiahui XuiD· 1 shared Jiawen LiiD· 1 shared Jing Su· 1 shared Min LiiD· 1 shared Qiongqiong Hou· 1 shared Tobias Magers· 1 shared William M Bracken· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Caleb Schmicker

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintMay 27, 2024

The 11β-hydroxysteroid dehydrogenase type 1 inhibitor SPI-62 prevents morbidity in a mouse model of Cushing's syndrome

Xingyu Pan, Qiongqiong Hou, Jing Su…·David A. Katz

SPI-62, an HSD-1 inhibitor, reduces GC-induced morbidity in a mouse Cushing's syndrome model by improving insulin sensitivity, reducing adiposity, and preventing skeletal myopathy.

DOI 10.1101/2024.05.27.596076

𝕏 PostBluesky